109 related articles for article (PubMed ID: 38123104)
1. Midlife insulin resistance, APOE genotype, and change in late-life brain beta-amyloid accumulation - A 5-year follow-up [
Pietilä E; Snellman A; Tuisku J; Helin S; Viitanen M; Jula A; Rinne JO; Ekblad LL
Neurobiol Dis; 2024 Jan; 190():106385. PubMed ID: 38123104
[TBL] [Abstract][Full Text] [Related]
2. Midlife insulin resistance,
Ekblad LL; Johansson J; Helin S; Viitanen M; Laine H; Puukka P; Jula A; Rinne JO
Neurology; 2018 Mar; 90(13):e1150-e1157. PubMed ID: 29476033
[TBL] [Abstract][Full Text] [Related]
3. Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
Gottesman RF; Schneider AL; Zhou Y; Coresh J; Green E; Gupta N; Knopman DS; Mintz A; Rahmim A; Sharrett AR; Wagenknecht LE; Wong DF; Mosley TH
JAMA; 2017 Apr; 317(14):1443-1450. PubMed ID: 28399252
[TBL] [Abstract][Full Text] [Related]
4. Association of Early β-Amyloid Accumulation and Neuroinflammation Measured With [
Toppala S; Ekblad LL; Tuisku J; Helin S; Johansson JJ; Laine H; Löyttyniemi E; Marjamäki P; Blennow K; Zetterberg H; Jula A; Viitanen M; Rinne JO
Neurology; 2021 Mar; 96(12):e1608-e1619. PubMed ID: 33514647
[TBL] [Abstract][Full Text] [Related]
5. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
Resnick SM; Bilgel M; Moghekar A; An Y; Cai Q; Wang MC; Thambisetty M; Prince JL; Zhou Y; Soldan A; Wong DF; O'Brien RJ; Ferrucci L; Albert MS
Neurobiol Aging; 2015 Aug; 36(8):2333-9. PubMed ID: 26004017
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
Okada Y; Kato T; Iwata K; Kimura Y; Nakamura A; Hattori H; Toyama H; Ishii K; Ishii K; Senda M; Ito K; Iwatsubo T;
Ann Nucl Med; 2020 Feb; 34(2):108-118. PubMed ID: 31749127
[TBL] [Abstract][Full Text] [Related]
7. APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
Snellman A; Ekblad LL; Tuisku J; Koivumäki M; Ashton NJ; Lantero-Rodriguez J; Karikari TK; Helin S; Bucci M; Löyttyniemi E; Parkkola R; Karrasch M; Schöll M; Zetterberg H; Blennow K; Rinne JO
Alzheimers Res Ther; 2023 Apr; 15(1):71. PubMed ID: 37016464
[TBL] [Abstract][Full Text] [Related]
8. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
9. Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions.
Toppala S; Ekblad LL; Lötjönen J; Helin S; Hurme S; Johansson J; Jula A; Karrasch M; Koikkalainen J; Laine H; Parkkola R; Viitanen M; Rinne JO
J Alzheimers Dis; 2019; 72(1):215-228. PubMed ID: 31561373
[TBL] [Abstract][Full Text] [Related]
10. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
[TBL] [Abstract][Full Text] [Related]
11. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
[TBL] [Abstract][Full Text] [Related]
12. Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.
Lopresti BJ; Campbell EM; Yu Z; Anderson SJ; Cohen AD; Minhas DS; Snitz BE; Royse SK; Becker CR; Aizenstein HJ; Mathis CA; Lopez OL; Klunk WE; Tudorascu DL
Neurobiol Aging; 2020 Oct; 94():111-120. PubMed ID: 32603776
[TBL] [Abstract][Full Text] [Related]
13. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
[TBL] [Abstract][Full Text] [Related]
14. Cortical ¹¹C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging".
Scheinin NM; Wikman K; Jula A; Perola M; Vahlberg T; Rokka J; Någren K; Viitanen M; Rinne JO
J Alzheimers Dis; 2014; 41(1):193-202. PubMed ID: 24603945
[TBL] [Abstract][Full Text] [Related]
15. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and body mass index are associated with TSPO PET in cognitively unimpaired elderly.
Ekblad LL; Tuisku J; Koivumäki M; Helin S; Rinne JO; Snellman A
J Cereb Blood Flow Metab; 2023 Sep; 43(9):1588-1600. PubMed ID: 37113066
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal patterns of β-amyloid deposition in nondemented older adults.
Sojkova J; Zhou Y; An Y; Kraut MA; Ferrucci L; Wong DF; Resnick SM
Arch Neurol; 2011 May; 68(5):644-9. PubMed ID: 21555640
[TBL] [Abstract][Full Text] [Related]
18. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.
Rinne JO; Brooks DJ; Rossor MN; Fox NC; Bullock R; Klunk WE; Mathis CA; Blennow K; Barakos J; Okello AA; Rodriguez Martinez de Liano S; Liu E; Koller M; Gregg KM; Schenk D; Black R; Grundman M
Lancet Neurol; 2010 Apr; 9(4):363-72. PubMed ID: 20189881
[TBL] [Abstract][Full Text] [Related]
19. Plasma based markers of [11C] PiB-PET brain amyloid burden.
Kiddle SJ; Thambisetty M; Simmons A; Riddoch-Contreras J; Hye A; Westman E; Pike I; Ward M; Johnston C; Lupton MK; Lunnon K; Soininen H; Kloszewska I; Tsolaki M; Vellas B; Mecocci P; Lovestone S; Newhouse S; Dobson R;
PLoS One; 2012; 7(9):e44260. PubMed ID: 23028511
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
